G3BP1 depletion, observed in Parkinson's Disease, drives Golgi-lysosome-autophagy defects.
G3BP1 depletion, observed in Parkinson's Disease, drives Golgi-lysosome-autophagy defects.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Cambridge, GB · Author affiliation
Cambridge Institute for Medical Research (CIMR), University of Cambridge, Cambridge, UK.Location evidence
A plain-language reading has not been prepared for this paper yet.
Original abstract
The RNA binding G3BP1 is depleted in several neurodegenerative diseases, yet its functional consequences at the cellular level remain poorly understood. While best known for its critical role in stress granule formation, we demonstrate that G3BP1 also stabilises the COPI vesicle protein beta-COP by promoting its interaction with the deubiquitinase USP10. G3BP1 depletion disrupts this interaction leading to increased ubiquitination of beta-COP, which accelerates its proteasomal degradation. This leads to compromised Golgi structure and function, and impaired lysosomal homeostasis, which causes defective autophagic flux. Consequently, the autophagic clearance of α-synuclein, a protein that can drive Parkinson's disease (PD), is significantly slowed. Importantly, we observe a concurrent reduction of both G3BP1 and beta-COP protein levels in brain sections from PD and dementia with Lewy Body (DLB) patients and from a PD mouse model. These findings reveal a novel mechanistic link between G3BP1, vesicular trafficking, and proteostasis in neurodegeneration.